SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Schedule of estimated useful life in years for property and equipment

Diagnostic equipment	5–13
Research, development and demonstration equipment	3-7
Machinery and equipment	2-7
Furniture and fixtures	3-9
Leasehold improvements	5–10
Building	28

Schedule of patient fee revenue - net

	For the Years Ended June 30
	2024		2023
Commercial Insurance/ Managed Care	$	4,952,712	$	4,124,646
Medicare/Medicaid		1,138,176		1,063,846
Workers’ Compensation/Personal Injury		20,673,483		18,670,019
Other		7,051,425		5,935,482
Net Patient Fee Revenue	$	33,815,796	$	29,793,993

Schedule of earnings per share

	June 30, 2024
Basic	Total		Common Stock		Class C Common Stock
Numerator:
Net income available to common stockholders	$	10,567,396	$	9,908,920	$	167,700
Denominator:
Weighted average shares outstanding		6,350,862		6,350,862		382,513
Basic income per common share	$	1.66	$	1.56	$	0.44
Diluted
Denominator:
Weighted average shares outstanding				6,350,862		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,478,366		382,513
Diluted income per common share			$	1.53	$	0.44

	June 30, 2023
Basic	Total		Common Stock		Class C Common Stock
Numerator:
Net income available to common stockholders	$	9,375,776	$	8,801,974	$	146,136
Denominator:
Weighted average shares outstanding		6,539,376		6,539,376		382,513
Basic income per common share	$	1.43	$	1.35	$	0.38
Diluted
Denominator:
Weighted average shares outstanding				6,539,376		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,666,880		382,513
Diluted income per common share			$	1.32	$	0.38